Current Approaches in Managing Colonic Serrated Polyps and Serrated Polyposis

Area of Science:

• Gastroenterology
• Oncology
• Pathology

Background:

• Colorectal cancer (CRC) prevention historically focused on conventional adenomas as the primary precursor lesions.
• Recent discoveries highlight serrated polyps (SPs) as significant precursors to CRC, particularly sporadic cases.
• This necessitates a re-evaluation of CRC prevention, diagnosis, and treatment strategies.

Purpose of the Study:

• To review the current understanding of serrated polyps (SPs) and their role in colorectal cancer (CRC) development.
• To discuss the implications of SPs for CRC prevention, diagnosis, and treatment.
• To highlight areas requiring further research in serrated neoplasia and serrated polyposis syndrome (SPS) management.

Main Methods:

• Literature review of recent studies on serrated polyps and associated colorectal cancer.
• Analysis of current understanding regarding SP terminology, detection, resection, and surveillance.
• Reflection on the clinical management of serrated polyposis syndrome (SPS).

Main Results:

• Serrated polyps (SPs) represent a distinct pathway to colorectal cancer (CRC), challenging the traditional adenoma-centric view.
• A significant proportion of sporadic CRCs may arise from SPs.
• Current knowledge on SPs requires further development in terminology, detection, and management strategies.

Conclusions:

• The recognition of serrated polyps (SPs) as CRC precursors marks a paradigm shift in the field.
• Improved understanding and standardized management protocols for SPs and serrated polyposis syndrome (SPS) are crucial.
• Continued research is essential to optimize CRC prevention and patient outcomes related to serrated lesions.